With the United States Food and Drug Administration (USFDA) disapproving Sun Pharma Advanced Research Company's (Sparc) new drug application for an... ...http://www.thehindubusinessline.com/companies/sun-pharma-reviewing-antidepressants-viability-after-fda-response/article5473857.ece
11:50am Market Update The market maintained its positive momentum. The Sensex rallied 198.53 points or 0.96 percent to 20,810.67, and the Nifty... ...http://www.moneycontrol.com/news/local-markets/sensex-gains-200-pts-after-rbi-keeps-policy-rates-unchanged_1010198.html
Sun Pharma Advanced Research Company (SPARC) has received a Complete Response Letter from the US Food and Drug Administration (USFDA) on its New... ...http://www.indian-commodity.com/corporate/sparc-receives-complete-response-letter-from-usfda-on-venlafaxine-nda.aspx
NEW DELHI: or SPARC slipped as much as 8.4 per cent in trade on Wednesday, after the US health regulator disapproved its ( NDA) for an... ...http://economictimes.indiatimes.com/markets/stocks/stocks-in-news/sparc-drops-over-8-as-usfda-disapproves-drug-in-present-form/articleshow/27569912.cms
The troubled drug maker, Wockhardt, which came under strict scrutiny by two international drug regulators, has got a breather, thanks to its less... ...http://www.mydigitalfc.com/news/despite-ban-uk-watchdog-ease-wockhardt-drugs-228
Venlafaxine or Effexor could be a...